These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7905233)

  • 1. Necrotizing vasculitis--relapse despite cytotoxic therapy.
    Gordon M; Luqmani RA; Adu D; Greaves I; Richards N; Michael J; Emery P; Bacon PA
    Adv Exp Med Biol; 1993; 336():477-81. PubMed ID: 7905233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapses in patients with a systemic vasculitis.
    Gordon M; Luqmani RA; Adu D; Greaves I; Richards N; Michael J; Emery P; Howie AJ; Bacon PA
    Q J Med; 1993 Dec; 86(12):779-89. PubMed ID: 7906421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytostatic drugs in the treatment of severe vasculitides. Indications, results and risks.
    Kaeser HE
    Eur Neurol; 1984; 23(6):407-9. PubMed ID: 6150853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis.
    Adu D; Pall A; Luqmani RA; Richards NT; Howie AJ; Emery P; Michael J; Savage CO; Bacon PA
    QJM; 1997 Jun; 90(6):401-9. PubMed ID: 9205678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial vasculitis: report of 2 families.
    Rottem M; Cotch MF; Fauci AS; Hoffman GS
    J Rheumatol; 1994 Mar; 21(3):561-3. PubMed ID: 7911836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: A prospective randomized study of one hundred twenty-four patients.
    Ribi C; Cohen P; Pagnoux C; Mahr A; Arène JP; Puéchal X; Carli P; Kyndt X; Le Hello C; Letellier P; Cordier JF; Guillevin L;
    Arthritis Rheum; 2010 Apr; 62(4):1186-97. PubMed ID: 20131268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Necrotizing mesenteric vasculitis after longstanding cutaneous polyarteritis nodosa.
    Dewar CL; Bellamy N
    J Rheumatol; 1992 Aug; 19(8):1308-11. PubMed ID: 1357171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide therapy of severe systemic necrotizing vasculitis.
    Fauci AS; Katz P; Haynes BF; Wolff SM
    N Engl J Med; 1979 Aug; 301(5):235-8. PubMed ID: 36563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.
    Jayne D; Rasmussen N; Andrassy K; Bacon P; Tervaert JW; Dadoniené J; Ekstrand A; Gaskin G; Gregorini G; de Groot K; Gross W; Hagen EC; Mirapeix E; Pettersson E; Siegert C; Sinico A; Tesar V; Westman K; Pusey C;
    N Engl J Med; 2003 Jul; 349(1):36-44. PubMed ID: 12840090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infectious complications of cyclophosphamide treatment for vasculitis.
    Bradley JD; Brandt KD; Katz BP
    Arthritis Rheum; 1989 Jan; 32(1):45-53. PubMed ID: 2563226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids.
    Miloslavsky EM; Specks U; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Ding L; Iklé D; Villareal M; Lim N; Brunetta P; Fervenza FC; Monach PA; Stone JH;
    Arthritis Rheumatol; 2015 Jun; 67(6):1629-36. PubMed ID: 25776953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular presentation of polyarteritis nodosa. Clinical course and management with steroid and cytotoxic therapy.
    Akova YA; Jabbur NS; Foster CS
    Ophthalmology; 1993 Dec; 100(12):1775-81. PubMed ID: 7903120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorine 18 fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of three patients with vasculitis.
    Bleeker-Rovers CP; Bredie SJ; van der Meer JW; Corstens FH; Oyen WJ
    Am J Med; 2004 Jan; 116(1):50-3. PubMed ID: 14706666
    [No Abstract]   [Full Text] [Related]  

  • 14. Long term azathioprine maintenance therapy in ANCA-associated vasculitis: combined results of long-term follow-up data.
    de Joode AAE; Sanders JSF; Puéchal X; Guillevin LP; Hiemstra TF; Flossmann O; Rasmussen N; Westman K; Jayne DR; Stegeman CA
    Rheumatology (Oxford); 2017 Nov; 56(11):1894-1901. PubMed ID: 28977502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients.
    Gayraud M; Guillevin L; le Toumelin P; Cohen P; Lhote F; Casassus P; Jarrousse B;
    Arthritis Rheum; 2001 Mar; 44(3):666-75. PubMed ID: 11263782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Microscopic polyangiitis].
    Pagnoux C; Guilpain P; Guillevin L
    Presse Med; 2007 May; 36(5 Pt 2):895-901. PubMed ID: 17350793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations.
    Fauci AS; Haynes B; Katz P
    Ann Intern Med; 1978 Nov; 89(5 Pt 1):660-76. PubMed ID: 31121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
    Jones RB; Furuta S; Tervaert JW; Hauser T; Luqmani R; Morgan MD; Peh CA; Savage CO; Segelmark M; Tesar V; van Paassen P; Walsh M; Westman K; Jayne DR;
    Ann Rheum Dis; 2015 Jun; 74(6):1178-82. PubMed ID: 25739829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of primary systemic vasculitis.
    Pusey CD; Gaskin G; Rees AJ
    APMIS Suppl; 1990; 19():48-50. PubMed ID: 2285540
    [No Abstract]   [Full Text] [Related]  

  • 20. Late recurrence of systemic vasculitis after kidney transplantation involving the kidney allograft.
    Fogazzi GB; Banfi G; Allegri L; Bignardi L
    Adv Exp Med Biol; 1993; 336():503-6. PubMed ID: 8296664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.